Pattern of dyslipidaemia among nigerians with type 2 diabetes mellitus

Nigerian Journal of Clinical Practice

Volumn 11, Issue 1, 2008, Pages 25-31

  Okafor, C I ^a   Fasanmade, O A ^a   Oke, D A ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Dyslipidaemia; Nigerians; Type 2 diabetes mellitus

Indexed keywords

LIPID;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MIDDLE AGED; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICS; TEACHING HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HOSPITALS, TEACHING; HUMANS; LIPIDS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE;

EID: 51149114014     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Yach D, Hawkes C, Gouuld CL, Hofman KJ. The Global Burden of Chronic Diseases. Overcoming the Impediments to Prevention and Control. JAMA 2004; 291:2616-2622.
2. Tonkin A. The Metabolic Syndrome A Growing Problem. European Heart Journal supplements 2004; 6: A32 A42.
3. Njeleka MA, Negishi H, Nara Y, Sato T, Tomohiro M, Kuga S et al. Obesity and Lipid profiles in middle-aged men and women in Tanzania. East Afr Med J. 2002; 79:58-64.
4. Akinkugbe OO. Non-communicable diseases in Nigeria: The Next Epidemics. Abayomi Memorial Lectures. Nig. J. of Med. Pract. 2000; 3; 904-907.
5. Ikem RT, Akinola NO, Balogun MO, Ohwovorlole AE, Akinsola A. What does the presence of hypertension portend in the Nigerian with non-insulin dependent diabetes mellitus? W. Afr. J. Med 2001; 20:127-130.
6. Agbola-Abu CF, Onabolu A. Plasma Lipid Level in patients attending Igbinedion Hospital and Medical Research Centre, Okada, Edo State. Nigeria. Nig. Med. J. 2000; 38:1-5
7. Al-Adsani A, Memon A, Suresh A. Pattern and Determinants of Dyslipidaemia in Type 2 Diabetes Mellitus patients in Kuwait. Acta Diabetol 2004; 41 (3): 129-135. (Pubitemid 39304489)
8. Vezl ZB, Naidoo DP. Dyslipidaemia among Black Patients with Type 2 Diabetes. Cardiovasc. J. S. Afr. 2005; 16 (4): 194-198.
9. Ko GT, Cockram CS, Critchley JA, Chan JC. Glycaemic Control and Obesity are the Major Determinants of Diabetic Dyslipidaemia in Hong Kong Chinese. Diabetes Metab. 2001; 27 (6): 637-644. (Pubitemid 34007858)
10. Otieno CF, Mwendwa FW, Vaghela V, Ogola EN, Amayo EO. Lipid Profile of Ambulatory Patients with Type 2 Diabetes ' Mellitus at Kenyatta National Hospital, Nairobi. East Afr Med J 2005; 82(12suppl): s173-179.
11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up Report on the Diagnosis of piabetes Mellitus. Diabetes Care 2003 26:3160-3167.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
13. Guidelines Subcommittee. 1999 WHO/ISH Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183
14. Levine JB, Zak B. Ferric Chloride Method of Determination of Total Cholesterol. Clin Chim Acta. 1964; 10:381-384.
15. Busterin M, Scbolnick HR, Morfin R. Rapid Method for the Isolation of Lipoproteins from Human Serum by Precipitation with Polyanions. J Lip Res. 1970; 11:583-595.
16. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of LowDensity Lipoprotein Cholesterol in Plasma without Use of Preparative Ultracentrifugation. Clin Chem. 1972; 18:499-502.
17. McGowan MW, Artiss JD, Strandergh DR, et al. Peroxidase-Coupled Method for the Calorimetric Determination of Serum Triglycerides. Clin Chem. 1983; 29:583-1542
18. Mgonda YM, Ramaiya KL, Swai ABM, McLarty DG, Alberti KGMM. Insulin Resistance and Hypertension in Non-obese Africans in Tanzania. Hypertension 1998; 31[part1]:114-118.
19. Hodge AM, Dowse GK, Toelupe P, Collins VR, Zimmet PZ. The Association of Modernization with Dyslpidaemia and Changes in Lipid Level in the Polynesian Population of Western Samoa. Int. J. Epidemiol. 1997; 26 (2): 297-306.
20. Onitiri A, Sander M, Boyo AE. Serum Lipids and Lipoproteins in Healthy Africans. Clin ChemActa 1977; 811:57-61.
21. Ukoli FAM, Bunker CH, Fabio A et al. Sex Differences in Serum Lipid Patterns and Their Correlates in a Nigerian Urban Elderly Population. Nig Med J 1997; 32(3): 85 89.
22. Akpa MR, Agomuoh DI, Alasia DD. Lipid Profile of Healthy Adult Nigerians in Port Harcourt, Nigeria. Nigerian Journal of Medicine 2006; 15(2): 137 140.
23. Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL et al. The Pattern of Dyslipidemia among Urban African-Americans with Type 2 Diabetes. Diabetes Care 2000; 23:319 324.
24. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and Diabetes Mellitus. Mayo Clin Proc.1998; 73:969-976.
25. 25. Ismail IS, Nazaimoon W, Mohamad W et al. Ethnicity and Glycaemic Control are Major Determinants of Diabetic Dyslipidaemia in Malaysia. Diabet Med. 2001; 18(6):501-508. (Pubitemid 32738701)
26. Bakari AG, Onyemelukwe GC. Indices of Obesity Among Type 2 Diabetic Hausa-Fulani Nigerians. Int J Diabetes and Metabolism 2005;13:28 29.
27. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF, 2005. Available at: http://www.idf.org/webdata/docs/idf-metasyndrome-definition.pdf (Accessed May 2005). The IDF Backgrounder 1.
28. Eid M, Mafauzy M, Faridah AR. Nonachievement of Clinical Targets in Patients with Type 2 Diabetes Mellitus. Med J Malaysia. 2004; 59(2): 177-184.
29. Kanters SD, Algra A, de Bruint TW, Erkelens DW, Banga JD. Intensive Lipidlowering Strategy in Patients with Diabetes Mellitus. Diabet Med. 1999; 16(6):500-508.
30. Thompson GR. Management of Dyslipidaemia. Heart 2004; 90: 949-955.